Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.71 -0.01 (-0.04%)
Official Closing Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates ↗
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade
News headline image
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Tops EPS Expectations In Q3 2025 Despite Revenue Decline ↗
Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year EPS guidance raise. 
Via Talk Markets
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies. 
Via The Motley Fool
Topics Energy Stocks
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise ↗
Via Stocktwits
News headline image
Check Out What Whales Are Doing With PFE ↗
 
Via Benzinga
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit ↗
Via Stocktwits
News headline image
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
Uber, AMD And 3 Stocks To Watch Heading Into Tuesday ↗
Stock futures trading lower, watch Uber, Upwork, AMD, Starbucks, Pfizer earnings. Starbucks forms China JV. Cramer advises against AT&T. 
Via Benzinga
News headline image
Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts ↗
Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, among others. 
Via Benzinga
News headline image
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
News headline image
Tech Titans Unite and Consumer Giants Merge: Amazon-OpenAI Partnership and Kenvue Buyout Ignite S&P 500 and Nasdaq Gains
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by... 
Via MarketMinute
Topics Artificial Intelligence Lawsuit Stocks
News headline image
Did Novo Nordisk Just Say "Checkmate" to Pfizer? ↗
These two leading drugmakers are fighting over a promising GLP-1 candidate. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo ↗
Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk. 
Via Investor's Business Daily
Topics Economy Lawsuit
News headline image
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗
BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization. 
Via Benzinga
News headline image
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle ↗
Pfizer sues Metsera and Novo Nordisk, alleging breach of contract and antitrust violations over a rival $9 billion bid challenging its $4.9 billion merger deal. 
Via Benzinga
Topics Lawsuit
News headline image
Insights Ahead: Pfizer's Quarterly Earnings ↗
 
Via Benzinga
News headline image
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon ↗
The healthcare industry is chock-full of opportunities for long-term investors. 
Via The Motley Fool
Topics Government World Trade
News headline image
How To Earn $500 A Month From Pfizer Stock Ahead Of Q3 Earnings ↗
Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly. 
Via Benzinga
News headline image
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday. 
Via Benzinga
News headline image
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
From Pfizer Inc.
Via Business Wire
News headline image
2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon ↗
These healthcare stocks are making strides in very important ways. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Meet the 7% Yield Dividend Stock That Could Soar in 2026 ↗
This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term. 
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
1 Incredible Reason to Buy Pfizer Stock (PFE) in November ↗
What would you say to a dividend yield of 7%? 
Via The Motley Fool
News headline image
3 Stocks Under $50 We’re Skeptical Of
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
News headline image
Pfizer (PFE) Q3 Earnings: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Is It Time to Dump Your Shares of Pfizer? ↗
Pfizer stock has dropped 50% over the past three years. 
Via The Motley Fool
Topics Intellectual Property
News headline image
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
News headline image
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal ↗
Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company. 
Via Investor's Business Daily
Topics Law Enforcement Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.